Olof Solin - UTU Research Portal - UTU Research Portal

Olof Solin

- Senior Advisor
Turku PET Centre (Independent units)

olosol@utu.fi

3 of 17

Automated GMP production and long-term experience in radiosynthesis of CB(1)tracer [F-18]FMPEP-d(2) (2020)
- Journal of Labelled Compounds and Radiopharmaceuticals
Salla Lahdenpohja, Thomas Keller, Sarita Forsback, Tapio Viljanen, Esa Kokkomäki, Riikka V. Kivelä, Jörgen Bergman,Olof Solin, Anna K. Kirjavainen
Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer’s disease (2020)
- Journal of Cerebral Blood Flow and Metabolism
Keller T., López-Picón F.R., Krzyczmonik A., Forsback S., Takkinen J.S., Rajander J., Teperi S., Dollé F., Rinne J.O., Haaparanta-Solin M., Solin O.
Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP (2020)
- ACS Chemical Neuroscience
Lahdenpohja S, Rajala N, Helin JS, Haaparanta-Solin M, Solin O, López-Picón FR, Kirjavainen A
[18F]SPA-RQ/PET Study of NK1 receptors in the Whole Body of Guinea Pig and Rat (2019)
- Scientific Reports
Tove J. Grönroos, Sarita Forsback, Olli Eskola, Jörgen Bergman, Päivi Marjamäki, Eliisa Löyttyniemi, Jarmo Hietala, Merja Haaparanta-Solin, Olof Solin
Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study (2019)
- Journal of Affective Disorders
Mikko Nyman, Olli Eskola, Jaana Kajander, Riitta Jokinen, Jukka Penttinen, Tomi Karjalainen, Lauri Nummenmaa, Jussi Hirvonen, Donald Burns, Richard Hargreaves, Olof Solin, Jarmo Hietala
Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation (2019)
- EJNMMI Research
Vainio SK, Dickens AM, Tuisku J, Eskola O, Solin O, Loyttyniemi E, Anthony DC, Rinne JO, Airas L, Haaparanta-Solin M
Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial (2019)
- Journal of Applied Physiology
Kumail K. Motiani, Anna M. Savolainen, Jussi Toivanen, Jari-Joonas Eskelinen, Minna Yli-Karjanmaa, Kirsi A. Virtanen, Virva Saunavaara, Marja A. Heiskanen, Riitta Parkkola, Merja Haaparanta-Solin, Olof Solin, Nina Savisto, Eliisa Löyttyniemi, Juhani Knuuti, Pirjo Nuutila, Kari K. Kalliokoski, Jarna C. Hannukainen
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients with First-Episode Psychosis (2019)
- JAMA Psychiatry
Borgan F., Laurikainen H., Veronese M., Marques T.R., Haaparanta-Solin M., Solin O., Dahoun T., Rogdaki M., Salokangas R.K.R., Karukivi M., Di Forti M., Turkheimer F., Hietala J., Howes O.
In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats (2019)
- Theranostics
López-Picón F, Kirjavainen AK, Forsback S, Takkinen JS, Peters D, Haaparanta-Solin M, Solin O
Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine (2019)
- Molecular Imaging and Biology
Krzyczmonik A., Keller T., López-Picón F., Forsback S., Kirjavainen A.K., Takkinen J.S., Wasilewska A., Scheinin M., Haaparanta-Solin M., Solin O.